CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $47,096,000 | +17.1% | 2,169,351 | -18.4% | 0.20% | +5.7% |
Q4 2020 | $40,212,000 | +48.8% | 2,657,796 | +25.1% | 0.19% | +38.1% |
Q3 2020 | $27,033,000 | -17.3% | 2,124,421 | +11.2% | 0.14% | -26.5% |
Q2 2020 | $32,675,000 | +71.5% | 1,910,821 | +32.5% | 0.19% | +53.7% |
Q1 2020 | $19,054,000 | -18.0% | 1,442,421 | 0.0% | 0.12% | +5.1% |
Q4 2019 | $23,237,000 | -31.9% | 1,442,421 | -22.7% | 0.12% | -37.8% |
Q3 2019 | $34,113,000 | -18.1% | 1,866,188 | -3.7% | 0.19% | -18.6% |
Q2 2019 | $41,671,000 | +116.5% | 1,938,188 | +97.5% | 0.23% | +108.1% |
Q1 2019 | $19,251,000 | +77.0% | 981,220 | +17.3% | 0.11% | +63.2% |
Q4 2018 | $10,876,000 | -18.5% | 836,642 | +50.2% | 0.07% | -4.2% |
Q3 2018 | $13,340,000 | +25.1% | 557,000 | 0.0% | 0.07% | +16.4% |
Q2 2018 | $10,666,000 | +373.2% | 557,000 | +205.9% | 0.06% | +369.2% |
Q1 2018 | $2,254,000 | +80.6% | 182,100 | +78.5% | 0.01% | +85.7% |
Q4 2017 | $1,248,000 | – | 102,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |